Back

Reverse septal curvature in hypertrophic cardiomyopathy: a marker of high-risk phenotype and adverse remodelling.

29 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Improved diagnosis of hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Roberto Polizzi

Federico II University Hospital, Napoly (Italy)

6 More presentations in this session

Presentation thumbnail
Founder novel mutations in hypertrophic cardiomyopathy patients in Italy
Doctor N. Fanciullo (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Impact of novel maximal wall thickness adjustments on arrhythmic event prediction in hypertrophic cardiomyopathy
Doctor R. Amador (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and UK
Doctor J. Wang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Integrating electrocardiogram into the Mayo score enhances genotype prediction in hypertrophic cardiomyopathy
Mr T. Hiruma (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Pathophysiological stratification of left ventricular hypertrophy using artificial intelligence-based electrocardiogram analysis
Mr D. Ahmetagic (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Improved diagnosis of hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Session
Hypertrophic cardiomyopathy: from gene to treatment
thumbnail
Congress Session
Septal reduction and myosin inhibitors: competing or complementary therapies?
thumbnail
Congress Presentation
Right ventricular longitudinal strain but not right ventricular ejection fraction in hypertrophic cardiomyopathy associates with sarcomere positive status and adverse phenotypes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources